Centralized Pan-Asian Survey on the Under Treatment of Hypercholesterolemia

NCT ID: NCT00687492

Last Updated: 2010-12-02

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

8000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2008-05-31

Study Completion Date

2008-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The survey will try to establish the proportion of patients on lipid-lowering pharmacological treatment reaching the LDL-C goals according to the third NCEP ATP guidelines, overall and by country.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hypercholesterolemia

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

hypercholesterolemia NCEP ATP III guidelines survey

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 2 or more risk factors (according to NCEP ATP III guideline)
* Receiving lipid-lowering drug treatment for at least 3 months without dosage change for a minimum of 6 weeks.

Exclusion Criteria

* Involvement in the planning and conduct of the study (applies to both AstraZeneca staff or staff at the study site).
* Previous enrolment or randomisation of treatment in the present study.
* Participation in a clinical study during the last 90 days.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

AstraZeneca

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

AstraZeneca

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Park Jeong Euy

Role: PRINCIPAL_INVESTIGATOR

Sungkyunkwan University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Research Site

Hong Kong, Hong Kong, China

Site Status

Research Site

Semarang, Central Java, Indonesia

Site Status

Research Site

Jakarta, DKI Jakarta, Indonesia

Site Status

Research Site

Sidoarjo, East Java, Indonesia

Site Status

Research Site

Surabaya, East Java, Indonesia

Site Status

Research Site

Medan, North Sumatra, Indonesia

Site Status

Research Site

Bandung, West Java, Indonesia

Site Status

Research Site

Bangsar, Kuala Lumpur, Malaysia

Site Status

Research Site

Kepong, Kuala Lumpur, Malaysia

Site Status

Research Site

Kuala Lumpur, Kuala Lumpur, Malaysia

Site Status

Research Site

Puchong, Kuala Lumpur, Malaysia

Site Status

Research Site

Setapak, Kuala Lumpur, Malaysia

Site Status

Research Site

Ampang, Selangor, Malaysia

Site Status

Research Site

Batu Caves, Selangor, Malaysia

Site Status

Research Site

Hulu Selangor, Selangor, Malaysia

Site Status

Research Site

Kampung Baru Subang, Selangor, Malaysia

Site Status

Research Site

Klang, Selangor, Malaysia

Site Status

Research Site

Kuala Selangor, Selangor, Malaysia

Site Status

Research Site

Petaling Jaya, Selangor, Malaysia

Site Status

Research Site

Port Klang, Selangor, Malaysia

Site Status

Research Site

Sekinchan, Selangor, Malaysia

Site Status

Research Site

Seri Kembangan, Selangor, Malaysia

Site Status

Research Site

Shah Alam, Selangor, Malaysia

Site Status

Research Site

Subang Jaya, Selangor, Malaysia

Site Status

Research Site

Sungai Buloh, Selangor, Malaysia

Site Status

Research Site

Sunway City, Selangor, Malaysia

Site Status

Research Site

Lipa, Batangas, Philippines

Site Status

Research Site

Baguio City, Benguet, Philippines

Site Status

Research Site

Davao City, Davao Region, Philippines

Site Status

Research Site

Iloilo City, Iloilo, Philippines

Site Status

Research Site

Manila, Manila, Philippines

Site Status

Research Site

Cheonan, Chung-Cheong-nam-do, South Korea

Site Status

Research Site

Bucheon-si, Gyeonggi-do, South Korea

Site Status

Research Site

Bundang, Gyeonggi-do, South Korea

Site Status

Research Site

Guri-si, Gyeonggi-do, South Korea

Site Status

Research Site

Il-san, Gyeonggi-do, South Korea

Site Status

Research Site

Suwon, Gyeonggi-do, South Korea

Site Status

Research Site

Masan, Gyung-sang-nam-do, South Korea

Site Status

Research Site

Busan, , South Korea

Site Status

Research Site

Daegu, , South Korea

Site Status

Research Site

Daejeon, , South Korea

Site Status

Research Site

Gwangju, , South Korea

Site Status

Research Site

Incheon, , South Korea

Site Status

Research Site

Jeju City, , South Korea

Site Status

Research Site

Seoul, , South Korea

Site Status

Research Site

Ulsan, , South Korea

Site Status

Research Site

Kaohsiung City, , Taiwan

Site Status

Research Site

Taichung, , Taiwan

Site Status

Research Site

Tainan City, , Taiwan

Site Status

Research Site

Taipei, , Taiwan

Site Status

Research Site

Taoyuan District, , Taiwan

Site Status

Research Site

Bangkoknoi, Bangkok, Thailand

Site Status

Research Site

Dusit, Bangkok, Thailand

Site Status

Research Site

Pathumwan, Bangkok, Thailand

Site Status

Research Site

Ratchathewi, Bangkok, Thailand

Site Status

Research Site

Klongluang, Changwat Pathum Thani, Thailand

Site Status

Research Site

Muang, ChiangMai, Thailand

Site Status

Research Site

Hanoi, Hanoi, Vietnam

Site Status

Research Site

Ho Chi Minh City, Hcmc, Vietnam

Site Status

Countries

Review the countries where the study has at least one active or historical site.

China Indonesia Malaysia Philippines South Korea Taiwan Thailand Vietnam

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

NIS-CAP-DUM-2008/1

Identifier Type: -

Identifier Source: org_study_id